or activation, influencing the expression of oncogenes and tumor
suppressor genes. Such alterations have
Erdman, V.V.,
Karimov, D.D.,
Tuktarova, I.A.,
Petintseva, A.A.,
Timasheva, Y.R.,
Nasibullin, T.R. (2025) 2, CDH4, SEMA6A, PKHD1L1, STK38L, HECW1, and TEAD1
genes, which are candidates of aging
contralateral brain tissues, was downloaded from the
Gene Expression Omnibus (GEO) database and screened
Mustafin, R.N.,
Bermisheva, M.A.,
Karunas, A.S.,
Akhmetshin, A.A.,
Monakhova, A.S.,
Khusnutdinova, E.K. (2025) of Bashkortostan, sequencing the NF1
gene in their DNA samples as well as whole genome sequencing using the WGS
Fedorova, Yu. Yu.,
Aminova, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Romanova, A.R.,
Nurgalieva, A.Kh.,
Andreeva, E.A.,
Darvish, M.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2025) RNA
gene methylation level in patients with different clinical parameters, including the stage of disease
different SNPs, most of which are located in intronic and intergenic regions where
genes encoding
Savelieva, Olga,
Karunas, Alexandra,
Prokopenko, Inga,
Balkhiyarova, Zhanna,
Gilyazova, Irina,
Khidiyatova, Irina,
Khusnutdinova, Elza (2025) SNPs of drug pathway
genes involved in the metabolism of glucocorticosteroids (GCS), and beta-2